Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.850
-0.430 (-8.14%)
Apr 30, 2026, 5:35 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €135.8 million as of May 1, 2026. Its market cap has decreased by -25.38% in one year.
Market Cap
135.80M
Enterprise Value
123.14M
Revenue
8.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.85
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 135.80M, a decrease of -44.50%. That is a compound annual growth rate of -9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 135.80M | -29.09% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.01B |
| argenx SE | 41.54B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.95M |
| European Medical Solutions | 22.22M |
| Celyad Oncology | 13.92M |
| BioSenic | 1.44M |
| Oxurion NV | 337.03K |